This large trial showed that chemotherapy plus involved-field radiotherapy was superior to subtotal nodal radiotherapy alone in patients with localized stage supradiaphragmatic Hodgkin's disease and risk factors for a good outcome. In patients with early-stage Hodgkin's disease and risk factors for a poor outcome, limited chemotherapy was as effective as a more aggressive course.
More...